Equatorial Guinea vs Luxembourg: Prevalence of hypertension, male
Equatorial Guinea
36.6%
in 2019
Luxembourg
36.6%
in 2019
Equatorial Guinea rank
101st
Luxembourg rank
101st
Prevalence of hypertension, male over time
- Equatorial Guinea
- Luxembourg
How they compare
Equatorial Guinea currently reports 36.6% against 36.6% in Luxembourg, a difference of 0.0%.
Across all 30 years both countries report, Luxembourg has been ahead every year.
Equatorial Guinea ranks 101st and Luxembourg ranks 101st of 192 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.7% | 46.7% | 9.0% | Luxembourg |
| 2000s | 38.4% | 46.0% | 7.7% | Luxembourg |
| 2010s | 37.5% | 40.4% | 2.9% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Equatorial Guinea or Luxembourg?
- Equatorial Guinea, at 36.6% against 36.6% in Luxembourg as of 2019.
- What is the difference in prevalence of hypertension, male between Equatorial Guinea and Luxembourg?
- 0.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Luxembourg?
- 30 years are reported by both, from 1990 to 2019.
- How do Equatorial Guinea and Luxembourg rank globally for prevalence of hypertension, male?
- Equatorial Guinea ranks 101st and Luxembourg ranks 101st of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.